Dianthus Therapeutics reaches early go decision in CIDP trial

March 9, 2026 7:01 AM

Dianthus Therapeutics Inc. (NASDAQ: DNTH) announced an early go decision for its Phase 3 CAPTIVATE trial of claseprubart in chronic ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found